NEW YORK, NY / ACCESSWIRE / April 3, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Luckin Coffee Inc. (LK)
LK Lawsuit on behalf of: investors who purchased May 17, 2019 - April 2, 2020
Lead Plaintiff Deadline: April 13, 2020
Join the action: https://www.zlk.com/pslra-1/luckin-coffee-inc-loss-form?wire=3&prid=5905
Allegations: Luckin Coffee Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) certain of Luckin's financial performance metrics, including per-store per-day sales, net selling price per item, advertising expenses, and revenue contribution from "other products" were inflated; (ii) Luckin's financial results thus overstated the Company's financial health and were consequently unreliable; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more about the Luckin Coffee Inc. class action, contact email@example.com.
Tilray, Inc. (TLRY)
TLRY Lawsuit on behalf of: investors who purchased January 15, 2019 - March 2, 2020
Lead Plaintiff Deadline: May 5, 2020
Join the action: https://www.zlk.com/pslra-1/tilray-inc-loss-form?wire=3&prid=5905
Allegations: Tilray, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the "ABG Agreement")were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more about the Tilray, Inc. class action, contact firstname.lastname@example.org.
AnaptysBio, Inc. (ANAB)
ANAB Lawsuit on behalf of: investors who purchased October 10, 2017 - November 7, 2019
Lead Plaintiff Deadline: May 26, 2020
Join the action: https://www.zlk.com/pslra-1/anaptysbio-inc-loss-form?wire=3&prid=5905
Allegations: AnaptysBio, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) AnaptysBio failed to disseminate important data from the Company's Phase 2a trial in atopic dermatitis, including the timing and extent of patients' use of topical corticosteroids as a rescue therapy during the study and whether any of the patients that utilized rescue therapy were classified as responders at a given time;and (ii) the Company's statements omitted key information from the Company's Phase 2a trial in peanut allergy, including patients' average cumulative peanut dose tolerated at day 14 after the administration of etokimab or placebo as well as whether the Company's decision to exclude 20% of the patients enrolled in the study from the interim analysis due to their mild symptoms was retrospective; and (ii) as a result of the foregoing, Defendants' positive statements about the efficacy and prospects of AnaptysBio's lead drug asset in the treatment of atopic dermatitis and peanut allergy were materially false and/or misleading and/or lacked a reasonable basis.
To learn more about the AnaptysBio, Inc. class action, contact email@example.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: